Authors:
SANDLER B
SMIRNOFF P
SHANI A
IDELEVICH E
PFEFFERMAN R
DAVIDOVICH B
ZUSMAN R
ZUSMAN I
Citation: B. Sandler et al., THE ROLE OF THE SOLUBLE P53 ANTIGEN AND ITS AUTOANTIBODIES AS MARKERSFOR DIAGNOSIS OF COLON-CANCER - A COMPARATIVE-STUDY, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(2), 1998, pp. 453-457
Authors:
GERESH S
VALIYAVEETTIL TJ
LAVIE Y
SHANI A
Citation: S. Geresh et al., CHEMOENZYMATIC SYNTHESIS OF (R)-(-2-METHYLBUTAN-1-OL, A CHIRAL SYNTHON FOR THE PREPARATION OF OPTICALLY-ACTIVE PHEROMONES()), Tetrahedron : asymmetry, 9(1), 1998, pp. 89-96
Citation: A. Shani et T. Stjernberg, INTRODUCTION TO THE SPECIAL ISSUE ON BUSINESS PROCESS REENGINEERING, Journal of organisational change management, 11(3), 1998, pp. 198-200
Citation: S. Binman et al., FUNCTIONALIZATION AT THE DOUBLE-BOND REGION OF JOJOBA OIL - 9 - SOLID-STATE NUCLEAR-MAGNETIC-RESONANCE CHARACTERIZATION OF SUBSTITUTED JOJOBA WAX CHEMICALLY BONDED TO A POLYSTYRENE MATRIX, Journal of the American Oil Chemists' Society, 75(4), 1998, pp. 521-525
Authors:
BRUFMAN G
COLAJORI E
GHILEZAN N
LASSUS M
MARTONI A
PEREVODCHIKOVA N
TOSELLO C
VIARO D
ZIELINSKI C
KRAINER M
SALZER H
SCHULLER J
DITTRICH C
SCHEITHAUER W
ZAMAGNI C
AMBROSINI G
COLUCCI G
GENTILINI P
ZANIBONI A
PACINI P
BIANCO R
MUSTACCHI G
DAPRILE M
DEMATTEIS A
OLIVEIRA C
JORDAAN J
GUDGEON A
VANZYL J
RAKOWSKY E
INBAR M
RATH P
COHEN Y
SHANI A
FRIED G
HEGG R
NETO AB
BADER G
BRAGA RF
VITOC C
PUERTO VML
VALLE AE
SALAZAR JD
SANCHEZ JC
VILLELA GM
FOUNTZILAS G
Citation: G. Brufman et al., DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/, Annals of oncology, 8(2), 1997, pp. 155-162
Authors:
YAM D
BENHUR H
DGANI R
FINK A
SHANI A
BERRY EM
Citation: D. Yam et al., SUBCUTANEOUS, OMENTUM AND TUMOR FATTY-ACID COMPOSITION, AND SERUM-INSULIN STATUS IN PATIENTS WITH BENIGN OR CANCEROUS OVARIAN OR ENDOMETRIAL TUMORS - DO TUMORS PREFERENTIALLY UTILIZE POLYUNSATURATED FATTY-ACIDS, Cancer letters, 111(1-2), 1997, pp. 179-185
Citation: A. Shani et J. Clearwater, HOW EFFICIENT ARE ALL-GLASS SYSTEMS FOR COLLECTION OF AIRBORNE VOLATILES, Journal of chemical ecology, 23(6), 1997, pp. 1621-1633
Citation: S. Binman et al., METAL SORPTION PROPERTIES OF SULFUR-CHLORINATED JOJOBA WAX BOUND TO POLYSTYRENE BEADS, Journal of applied polymer science, 63(5), 1997, pp. 625-633
Authors:
SREDNI B
TICHLER T
SHANI A
CATANE R
KAUFMAN B
STRASSMANN G
ALBECK M
KALECHMAN Y
Citation: B. Sredni et al., PREDOMINANCE OF TH1 RESPONSE IN TUMOR-BEARING MICE AND CANCER-PATIENTS TREATED WITH AS101, Journal of the National Cancer Institute, 88(18), 1996, pp. 1276-1284
Authors:
ZUSMAN I
ZUSMAN R
SANDLER B
KOROL D
GUREVICH P
SMIRNOFF P
BASS D
OR A
SHANI A
IDELEVICH E
Citation: I. Zusman et al., GEL FIBERGLASS AS A NEW MATRIX OF AFFINITY-CHROMATOGRAPHY COLUMNS FORISOLATION OF COLON CANCER-ASSOCIATED ANTIGENS, International journal of oncology, 9(1), 1996, pp. 153-157
Authors:
ZUSMAN I
ZUSMAN R
SANDLER B
KOROL D
GUREVICH P
SMIRNOFF P
BASS D
OR A
SHANI A
IDELEVICH E
HUSZAR M
TENDLER Y
KLEIN T
SHEZEN E
GLICK J
Citation: I. Zusman et al., HPLC DETERMINATION OF SERUM LEVELS OF SOLUBLE P53 ANTIGEN AS A NEW METHOD FOR COLON-CANCER DETECTION, AND ITS CLINICAL IMPLICATION, International journal of oncology, 8(6), 1996, pp. 1249-1256
Authors:
SREDNI B
TICHLER T
SHANI A
SHAPIRA J
BRUDERMAN I
ALBECK M
KALECHMAN Y
Citation: B. Sredni et al., BONE-MARROW SPARING AND PREVENTION OF ALOPECIA BY AS101 IN A RANDOMIZED PHASE-II STUDY ON NSCL CANCER-PATIENTS TREATED WITH CARBOPLATIN ANDETOPOSIDE, Experimental hematology, 24(9), 1996, pp. 351-351
Authors:
KALECHMAN Y
TICHLER T
SHANI A
ALBECK M
SREDNI B
Citation: Y. Kalechman et al., DIFFERENTIAL EFFECT OF THE IMMUNOMODULATOR AS101 ON B7-1 AND B7-2 COSTIMULATORY MOLECULES - ROLE IN TH1 PREDOMINANCE AND IN THE ANTITUMORALEFFECTS OF AS101, Experimental hematology, 24(9), 1996, pp. 392-392
Citation: Is. Saguy et al., UTILIZATION OF JOJOBA OIL FOR DEEP-FAT FRYING OF FOODS, Lebensmittel-Wissenschaft + Technologie, 29(5-6), 1996, pp. 573-577
Authors:
KALECHMAN Y
SHANI A
DOVRAT S
WHISNANT JK
METTINGER K
ALBECK M
SREDNI B
Citation: Y. Kalechman et al., THE ANTITUMORAL EFFECT OF THE IMMUNOMODULATOR AS101 AND PACLITAXEL (TAXOL) IN A MURINE MODEL OF LUNG ADENOCARCINOMA, The Journal of immunology, 156(3), 1996, pp. 1101-1109
Authors:
SREDNI B
XU RH
ALBECK M
GAFTER U
GAL R
SHANI A
TICHLER T
SHAPIRA J
BRUDERMAN I
CATANE R
KAUFMAN B
WHISNANT JK
METTINGER KL
KALECHMAN Y
Citation: B. Sredni et al., THE PROTECTIVE ROLE OF THE IMMUNOMODULATOR AS101 AGAINST CHEMOTHERAPY-INDUCED ALOPECIA STUDIES ON HUMAN AND ANIMAL-MODELS, International journal of cancer, 65(1), 1996, pp. 97-103
Citation: S. Binman et al., FUNCTIONALIZATION AT THE DOUBLE-BOND REGION OF JOJOBA OIL .7. CHEMICAL BINDING OF JOJOBA LIQUID WAX TO POLYSTYRENE RESINS, Journal of the American Oil Chemists' Society, 73(9), 1996, pp. 1075-1081
Citation: S. Binman et al., FUNCTIONALIZATION AT THE DOUBLE-BOND REGION OF JOJOBA OIL .8. CHEMICAL-BINDING OF JOJOBA LIQUID WAX TO A POLYMER MATRIX VIA AN AMINE SPACER, Journal of the American Oil Chemists' Society, 73(9), 1996, pp. 1083-1095
Authors:
SREDNI B
ALBECK M
TICHLER T
SHANI A
SHAPIRA J
BRUDERMAN I
CATANE R
KAUFMAN B
KALECHMAN Y
Citation: B. Sredni et al., BONE MARROW-SPARING AND PREVENTION OF ALOPECIA BY AS1O1 IN NON-SMALL-CELL LUNG-CANCER PATIENTS TREATED WITH CARBOPLATIN AND ETOPOSIDE, Journal of clinical oncology, 13(9), 1995, pp. 2342-2353
Authors:
KALECHMAN Y
SHANI A
DOVRAT S
ALBECK M
BRUCKNER HW
SREDNI B
Citation: Y. Kalechman et al., SYNERGISTIC ANTITUMOR EFFECT OF THE IMMUNOMODULATOR ASIOI AND TAXOL IN EXPERIMENTAL MURINE MODEL, Experimental hematology, 23(8), 1995, pp. 799-799
Authors:
SREDNI B
SHANI A
SHAPIRA J
BRUDERMAN I
ALBECK M
KALECHMAN Y
TICHLER T
Citation: B. Sredni et al., BONE-MARROW SPARING AND PREVENTION OF ALOPECIA BY ASIOI IN A RANDOMIZED PHASE-II STUDY ON NSCL CANCER-PATIENTS TREATED WITH CARBOPLATIN ANDVP-16, Experimental hematology, 23(8), 1995, pp. 858-858
Citation: Y. Kalechman et al., INDUCTION OF ACUTE-PHASE PROTEINS IN MICE AND HUMANS BY TREATMENT WITH AS101, AN IMMUNOMODULATOR WITH RADIOPROTECTIVE PROPERTIES, Immunopharmacology, 29(2), 1995, pp. 149-158